课题基金 / 基金详情

Kalirin-7 is essential in cocaine signaling: focus on nucleus accumbens

Kalirin-7 is essential in cocaine signaling: focus on nucleus accumbens
Kalirin-7 在可卡因信号传导中至关重要:关注伏隔核
批准号:
8413625
负责人:
Drew Kiraly
金额:
$2.5万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-12-15 至 2013-06-17

项目摘要

项目成果

Drew Kiraly的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):药物成瘾是当今社会对公共健康的重大损害,对使用非法药物的人及其家人造成终身影响。滥用药物最令人烦恼的问题之一是,即使得到适当的治疗,成瘾者也有很大的复发倾向。在动物模型中,长时间给药后最一致的发现之一是大脑特定区域树突棘的数量增加。这些结构性变化即使在长期退出之后仍然存在。在我们的实验室中,我们研究了一种蛋白质Kalirin-7,它与树突棘的形成和维持有关。我们的假设是,这种树突棘的增加在药物滥用的长期影响中起作用,并且Kalirin-7是结构变化中的重要参与者。我们将使用Kalirin-7(Kal 7 KO)基因缺陷的小鼠来确定它们对可卡因的行为或生化反应是否与野生型小鼠不同。最初的研究表明,Kal 7 KO小鼠对可卡因的运动致敏作用过敏,但对可卡因的位置偏好降低。我们现在正试图阐明Kalirin-7通过将可卡因的位置偏好与受体拮抗剂的共同给药相结合来调节的具体途径(目的1)。有趣的是,当使用增加Wt动物的脑桥核中树突棘的可卡因给药方案时,Kal 7 KO动物不显示树突棘的增加。下一步,我们将使用表达由多巴胺1受体启动子驱动的GFP的小鼠来检查Kal 7在纹状体神经元的特定亚群中的表达和形态学效应(Aim 2)。纹状体中的不同神经元群体在成瘾过程中发挥着不同的作用,了解它们的功能对于理解成瘾至关重要。此外,我们最近发现Kal 7 KO动物改变了NMDA受体NR 2B亚基的表面运输。NMDA受体的适当功能对于学习和记忆的正常可塑性是必不可少的,并且已经显示改变的NMDA受体功能在药物成瘾的发展中起作用。使用细胞培养模型和可卡因处理动物的组织,我们现在正在研究Kalirin-7和NR 2B之间的特异性相互作用,以及Kalirin-7如何改变这种关键受体的定位和运输(目的3)。当这些研究完成后,我们希望能大大扩展神经元形态学和受体运输的改变在药物成瘾的病理生理学中所起作用的知识。
英文摘要
DESCRIPTION (provided by applicant): Drug addiction is a major detriment to public health in today's society, with lifelong effects on people who use illicit drugs and their families. One of the most vexing problems with drugs of abuse is that addicts have a tremendous propensity to relapse, even with proper treatment. In animal models, one of the most consistent findings after prolonged drug administration is an increase in the number of dendritic spines in specific regions of the brain. These structural changes remain even after long periods of withdrawal. In our lab, we work on a protein, Kalirin-7, that has been implicated in the formation and maintenance of dendritic spines. It is our hypothesis that this increase in dendritic spines plays a role in the long-term effects of drug abuse, and that Kalirin-7 is an essential player in the structural changes. We will be using a line of mice genetically deficient in Kalirin-7 (Kal7KO) to determine if their behavioral or biochemical response to cocaine is different from that of wildtype mice. Initial studies have shown that the Kal7KO mice are hypersensitive to the locomotor sensitization effects of cocaine, yet show decreased place preference for cocaine. We are now trying to clarify the specific pathways that Kalirin-7 modulates by combining place preference for cocaine with co-administration of receptor antagonists (Aim 1). Interestingly, when using a cocaine dosing regimen that increases dendritic spines in the nucleus accumbens of Wt animals, Kal7KO animals do not show an increase in dendritic spines. Moving forward, we will be using mice expressing GFP driven by the dopamine 1 receptor promoter to examine the expression and morphological effect of Kal7 in specific subsets of striatal neurons (Aim 2). The different populations of neurons in the striatum play different roles in the addiction process, and understanding of their function is critical for the understanding of addiction. Additionally, we have recently discovered that Kal7KO animals have altered surface trafficking of the NR2B subunit of NMDA receptors. Proper function of NMDA receptors is essential for the normal plasticity underlying learning and memory, and altered NMDA receptor function has been shown to play a role in the development of drug addiction. Using both cell culture models and tissue from cocaine treated animals we are now investigating the specific interaction between Kalirin-7 and NR2B, and how Kalirin-7 alters the localization and trafficking of this critical receptor (Aim 3). When these studies are finished, we hope to have greatly expanded the knowledge of the roles that alterations in neuronal morphology and receptor trafficking play in the pathophysiology of drug addiction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting gut brain-signaling to reduce cocaine seeking behaviors
Targeting the host metabolome to reverse drug-induced epigenetic changes
Targeting the host metabolome to reverse drug-induced epigenetic changes
Targeting the host metabolome to reverse drug-induced epigenetic changes
海外基金